Fundraising September 15, 2024 – October 1, 2024 About fundraising

The Oral Proteasome Inhibitor Ixazomib in Combination with...

The Oral Proteasome Inhibitor Ixazomib in Combination with Melphalan-Prednisone (MP) for Patients with Newly Diagnosed Multiple Myeloma (NDMM): Phase 1/2 Dose-Escalation Study (NCT01335685)

San Miguel, Jesus, Echeveste Gutierrez, Maria Asunción, Špicka, Ivan, Mateos, María-Victoria, Song, Kevin, Craig, Michael, Bladé, Joan, Hájek, Roman, Chen, Christine, Gupta, Neeraj, Byrne, Catriona, L
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2017.07.153
Date:
September, 2017
File:
PDF, 93 KB
english, 2017
Conversion to is in progress
Conversion to is failed